IPCA Labs, Zydus Takeda, Mangalam Drugs & Organics and Wallace Pharma are among the manufacturers of this drug that are staring at fluctuating freight rates, a jump in prices of bulk drugs from Chinese suppliers and an erratic supply chain with cancelled or reduced frequency of cargo flights.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dPPNkW
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Covid-19: Indian pharma companies want government to airlift APIs from China
0 comments:
Post a Comment